Abstract 545: Differential mRNA Expression is Influenced by Apolipoprotein A-I in Order to Promote Foam Cell Regression

2016 ◽  
Vol 36 (suppl_1) ◽  
Author(s):  
Elisa C Maruko ◽  
Hao Xu ◽  
Sushma Kaul ◽  
Brian J Capaldo ◽  
Nathalie Pamir ◽  
...  
Keyword(s):  
Gene Expression ◽  
Differential Expression ◽  
Expression Analysis ◽  
Immune Cell ◽  
Foam Cell ◽  
Differential Expression Analysis ◽  
Ldl Receptor ◽  
Gene Set Enrichment Analysis ◽  
Control Group ◽  
Apolipoprotein A

Atherosclerosis is a disease of both lipids and inflammatory immune cells. More specifically, elevated plasma levels of low-density lipoproteins (LDL) leads to migration of circulating monocytes into the artery wall. Lipid loaded monocyte cells subsequently proliferate in the arterial walls becoming macrophage foam cells; a hallmark of atherosclerotic lesions. A proposed mechanism of the protective effects of high-density lipoprotein (HDL) is apolipoprotein A-I (apo A-I) acting as a mediator of cholesterol efflux and subsequent foam cell regression. To better understand the biological changes stimulated by apo A-I treatment, differential expression analysis of microarray data was performed on spleen cells from apo A-I treated mice. LDL receptor null (LDLr -/- ) and LDL receptor and apo A-I null (LDLr -/- , apoA-I -/- ) mice were fed a western diet consisting of 0.2% cholesterol and 42% of calories as fat for 12 weeks. After 6 weeks of diet, a subset of mice for each genotype was subcutaneously injected with 200 micrograms of apo A-I 3 times a week for the remaining 6 weeks. The control group mice were subcutaneously injected with 200 micrograms of saline or BSA. Spleen cell RNA was isolated, purified, and analyzed for differential expression analysis using Illumina BeadArray Microarray Technology Analysis. Individual gene expression analysis for LDLr -/- , apoA-I -/- apo A-I treated mice showed 281 significantly differentially expressed genes compared to BSA treated mice. LDLr -/- A-I treated mice had 1502. Of the significant genes, 189 intersected across both genotypes. LDLr -/- , apoA-I -/- A-I mice showed 73 up-regulated and 116 down-regulated genes. Similarly, LDLr -/- A-I mice had 71 up-regulated and 118 down-regulated. One-directional Gene Set Enrichment Analysis (GSEA) of LDLr -/- , apoA-I -/- A-I mice revealed 49 significant pathways while a total of 63 were found for LDLr -/- . Of these pathways, 21 were up-regulated and 13 were down-regulated in both genotypes. Eight of the top 10 most significant up-regulated pathways in both genotypes were immune cell related. Their functions involve receptor, adhesion, and chemokine signaling. Overall, preliminary analysis suggests A-I treatment induces similar gene expression changes across different genotypes.

scholarly journals Easy and efficient ensemble gene set testing with EGSEA

F1000Research ◽  
2017 ◽  
Vol 6 ◽  
pp. 2010 ◽  
Author(s):  
Monther Alhamdoosh ◽  
Charity W. Law ◽  
Luyi Tian ◽  
Julie M. Sheridan ◽  
Milica Ng ◽  
...  
Keyword(s):  
Gene Expression ◽  
Differential Expression ◽  
Expression Analysis ◽  
Differential Expression Analysis ◽  
Enrichment Analysis ◽  
Gene Set Enrichment Analysis ◽  
Gene Set ◽  
P Gene ◽  
Wide Range ◽  
Gene Set Testing

Gene set enrichment analysis is a popular approach for prioritising the biological processes perturbed in genomic datasets. The Bioconductor project hosts over 80 software packages capable of gene set analysis. Most of these packages search for enriched signatures amongst differentially regulated genes to reveal higher level biological themes that may be missed when focusing only on evidence from individual genes. With so many different methods on offer, choosing the best algorithm and visualization approach can be challenging. The EGSEA package solves this problem by combining results from up to 12 prominent gene set testing algorithms to obtain a consensus ranking of biologically relevant results.This workflow demonstrates how EGSEA can extend limma-based differential expression analyses for RNA-seq and microarray data using experiments that profile 3 distinct cell populations important for studying the origins of breast cancer. Following data normalization and set-up of an appropriate linear model for differential expression analysis, EGSEA builds gene signature specific indexes that link a wide range of mouse or human gene set collections obtained from MSigDB, GeneSetDB and KEGG to the gene expression data being investigated. EGSEA is then configured and the ensemble enrichment analysis run, returning an object that can be queried using several S4 methods for ranking gene sets and visualizing results via heatmaps, KEGG pathway views, GO graphs, scatter plots and bar plots. Finally, an HTML report that combines these displays can fast-track the sharing of results with collaborators, and thus expedite downstream biological validation. EGSEA is simple to use and can be easily integrated with existing gene expression analysis pipelines for both human and mouse data.

scholarly journals B-Cell and Monocyte Contribution to Systemic Lupus Erythematosus Identified by Cell-Type-Specific Differential Expression Analysis in RNA-Seq Data

2015 ◽  
Vol 9s3 ◽  
pp. BBI.S29470 ◽  
Author(s):  
Mikhail G. Dozmorov ◽  
Nicolas Dominguez ◽  
Krista Bean ◽  
Susan R. Macwana ◽  
Virginia Roberts ◽  
...  
Keyword(s):  
Gene Expression ◽  
B Cell ◽  
Differential Expression ◽  
Expression Analysis ◽  
Lupus Erythematosus ◽  
Differential Expression Analysis ◽  
Specific Gene ◽  
Cell Type ◽  
Specific Gene Expression ◽  
Cell Type Specific

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by complex interplay among immune cell types. SLE activity is experimentally assessed by several blood tests, including gene expression profiling of heterogeneous populations of cells in peripheral blood. To better understand the contribution of different cell types in SLE pathogenesis, we applied the two methods in cell-type-specific differential expression analysis, csSAM and DSection, to identify cell-type-specific gene expression differences in heterogeneous gene expression measures obtained using RNA-seq technology. We identified B-cell-, monocyte-, and neutrophil-specific gene expression differences. Immunoglobulin-coding gene expression was altered in B-cells, while a ribosomal signature was prominent in monocytes. On the contrary, genes differentially expressed in the heterogeneous mixture of cells did not show any functional enrichment. Our results identify antigen binding and structural constituents of ribosomes as functions altered by B-cell- and monocyte-specific gene expression differences, respectively. Finally, these results position both csSAM and DSection methods as viable techniques for cell-type-specific differential expression analysis, which may help uncover pathogenic, cell-type-specific processes in SLE.

scholarly journals A guide to creating design matrices for gene expression experiments

F1000Research ◽  
2020 ◽  
Vol 9 ◽  
pp. 1444
Author(s):  
Charity W. Law ◽  
Kathleen Zeglinski ◽  
Xueyi Dong ◽  
Monther Alhamdoosh ◽  
Gordon K. Smyth ◽  
...  
Keyword(s):  
Gene Expression ◽  
Data Analysis ◽  
Differential Expression ◽  
Rna Sequencing ◽  
Expression Analysis ◽  
Graphical Representation ◽  
Differential Expression Analysis ◽  
Data Types ◽  
Software Packages ◽  
Set Up

Differential expression analysis of genomic data types, such as RNA-sequencing experiments, use linear models to determine the size and direction of the changes in gene expression. For RNA-sequencing, there are several established software packages for this purpose accompanied with analysis pipelines that are well described. However, there are two crucial steps in the analysis process that can be a stumbling block for many -- the set up an appropriate model via design matrices and the set up of comparisons of interest via contrast matrices. These steps are particularly troublesome because an extensive catalogue for design and contrast matrices does not currently exist. One would usually search for example case studies across different platforms and mix and match the advice from those sources to suit the dataset they have at hand. This article guides the reader through the basics of how to set up design and contrast matrices. We take a practical approach by providing code and graphical representation of each case study, starting with simpler examples (e.g. models with a single explanatory variable) and move onto more complex ones (e.g. interaction models, mixed effects models, higher order time series and cyclical models). Although our work has been written specifically with a limma-style pipeline in mind, most of it is also applicable to other software packages for differential expression analysis, and the ideas covered can be adapted to data analysis of other high-throughput technologies. Where appropriate, we explain the interpretation and differences between models to aid readers in their own model choices. Unnecessary jargon and theory is omitted where possible so that our work is accessible to a wide audience of readers, from beginners to those with experience in genomics data analysis.

scholarly journals Exploring microRNA target genes and identifying hub genes in bladder cancer based on bioinformatic analysis

BMC Urology ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Hongjian Wu ◽  
Wubing Jiang ◽  
Guanghua Ji ◽  
Rong Xu ◽  
Gaobo Zhou ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Differential Expression ◽  
Expression Analysis ◽  
Target Genes ◽  
Cancer Genomics ◽  
Differential Expression Analysis ◽  
Gene Set Enrichment Analysis ◽  
Differentially Expressed ◽  
Tumour Suppressor Genes ◽  
Hub Genes

Abstract Background Bladder cancer (BC) is the second most frequent malignancy of the urinary system. The aim of this study was to identify key microRNAs (miRNAs) and hub genes associated with BC as well as analyse their targeted relationships. Methods According to the microRNA dataset GSE112264 and gene microarray dataset GSE52519, differentially expressed microRNAs (DEMs) and differentially expressed genes (DEGs) were obtained using the R limma software package. The FunRich software database was used to predict the miRNA-targeted genes. The overlapping common genes (OCGs) between miRNA-targeted genes and DEGs were screened to construct the PPI network. Then, gene ontology (GO) analysis was performed through the “cluster Profiler” and “org.Hs.eg.db” R packages. The differential expression analysis and hierarchical clustering of these hub genes were analysed through the GEPIA and UCSC Cancer Genomics Browser databases, respectively. KEGG pathway enrichment analyses of hub genes were performed through gene set enrichment analysis (GSEA). Results A total of 12 DEMs and 10 hub genes were identified. Differential expression analysis of the hub genes using the GEPIA database was consistent with the results for the UCSC Cancer Genomics Browser database. The results indicated that these hub genes were oncogenes, but VCL, TPM2, and TPM1 were tumour suppressor genes. The GSEA also showed that hub genes were most enriched in those pathways that were closely associated with tumour proliferation and apoptosis. Conclusions In this study, we built a miRNA-mRNA regulatory targeted network, which explores an understanding of the pathogenesis of cancer development and provides key evidence for novel targeted treatments for BC.

scholarly journals Evaluation of the Ankylosing Spondylitis Transcriptome for Oxidative Phosphorylation Pathway: The Shared Pathway with Neurodegenerative Diseases

2021 ◽  
Author(s):  
Arezou Lari ◽  
Hamid Gholami Pourbadie ◽  
Ali Sharifi-Zarchi ◽  
Saeed Aslani ◽  
Leila Nejatbakhsh Samimi ◽  
...  
Keyword(s):  
Gene Expression ◽  
Ankylosing Spondylitis ◽  
Oxidative Phosphorylation ◽  
Expression Analysis ◽  
Gene Expression Analysis ◽  
Mononuclear Cells ◽  
Differential Expression Analysis ◽  
Gene Set Enrichment Analysis ◽  
Inflammatory Disorder ◽  
Prevalence Of Dementia

Ankylosing spondylitis (AS) is a systemic inflammatory disorder of joints and entheses. Recent studies have reported an increased prevalence of dementia in AS patients. However, data for exploring the association between dementia and AS remain uncertain. In this study, enriched pathways and differentially expressed genes (DEGs) were identified in whole blood transcription data of AS patients obtained from the gene expression omnibus (GEO) database; using gene set enrichment analysis (GSEA) and differential expression analysis. Four pathways, including oxidative phosphorylation, Alzheimer’s, Parkinson’s, and Huntington’s diseases were significantly enriched in AS patients compared to the controls. We identified 22 common genes among the pathways that showed an increasing trend in AS compared to the controls. Five of them including COX7B, NDUFB3, ATP5PF, UQCRB, and NDUFS4 were the most significant genes which were selected for gene expression analysis; using real-time PCR on RNA contents of peripheral blood mononuclear cells (PBMCs) of AS patients and controls (20 samples from each group). The gene expression analysis indicated considerable overexpression of COX7B (p<0.0001) and ATP5J (p=0.0001) genes in AS patients group in comparison to the control samples. The role of oxidative phosphorylation has previously been established in dementia pathogenesis. Given that AS patients have also a remarkably higher prevalence of dementia than the their healthy counterparts, hence our results may propose that the common pathway of oxidative phosphorylation can be regarded as a possible shared contributing factor in the etiopathogenesis of AS and dementia.

scholarly journals Differential gene expression analysis tools exhibit substandard performance for long non-coding RNA–sequencing data

2017 ◽  
Author(s):  
Alemu Takele Assefa ◽  
Katrijn De Paepe ◽  
Celine Everaert ◽  
Pieter Mestdagh ◽  
Olivier Thas ◽  
...  
Keyword(s):  
Gene Expression ◽  
Differential Expression ◽  
Expression Analysis ◽  
Web Application ◽  
Empirical Bayes ◽  
Performance Metrics ◽  
Differential Expression Analysis ◽  
Rna Seq ◽  
Sequencing Data ◽  
Normalization Methods

ABSTRACTBackgroundProtein-coding RNAs (mRNA) have been the primary target of most transcriptome studies in the past, but in recent years, attention has expanded to include long non-coding RNAs (lncRNA). lncRNAs are typically expressed at low levels, and are inherently highly variable. This is a fundamental challenge for differential expression (DE) analysis. In this study, the performance of 14 popular tools for testing DE in RNA-seq data along with their normalization methods is comprehensively evaluated, with a particular focus on lncRNAs and low abundant mRNAs.ResultsThirteen performance metrics were used to evaluate DE tools and normalization methods using simulations and analyses of six diverse RNA-seq datasets. Non-parametric procedures are used to simulate gene expression data in such a way that realistic levels of expression and variability are preserved in the simulated data. Throughout the assessment, we kept track of the results for mRNA and lncRNA separately. All statistical models exhibited inferior performance for lncRNAs compared to mRNAs across all simulated scenarios and analysis of benchmark RNA-seq datasets. No single tool uniformly outperformed the others.ConclusionOverall, the linear modeling with empirical Bayes moderation (limma) and the nonparametric approach (SAMSeq) showed best performance: good control of the false discovery rate (FDR) and reasonable sensitivity. However, for achieving a sensitivity of at least 50%, more than 80 samples are required when studying expression levels in a realistic clinical settings such as in cancer research. About half of the methods showed severe excess of false discoveries, making these methods unreliable for differential expression analysis and jeopardizing reproducible science. The detailed results of our study can be consulted through a user-friendly web application, http://statapps.ugent.be/tools/AppDGE/

scholarly journals Topconfects: a package for confident effect sizes in differential expression analysis provides improved usability ranking genes of interest

2018 ◽  
Author(s):  
Paul F. Harrison ◽  
Andrew D. Pattison ◽  
David R. Powell ◽  
Traude H. Beilharz
Keyword(s):  
Gene Expression ◽  
Differential Expression ◽  
Expression Analysis ◽  
Effect Size ◽  
Differential Expression Analysis ◽  
R Package ◽  
Confidence Bound ◽  
Data Set ◽  
Cancer Data ◽  
Wide Range

AbstractBackgroundA differential gene expression analysis may produce a set of significantly differentially expressed genes that is too large to easily investigate, so that a means of ranking genes by their biological interest level is desirable. The life-sciences have grappled with the abuse of p-values to rank genes for this purpose. As an alternative, a lower confidence bound on the magnitude of Log Fold Change (LFC) could be used to rank genes, but it has been unclear how to reconcile this with the need to perform False Discovery Rate (FDR) correction. The TREAT test of McCarthy and Smyth is a step in this direction, finding genes significantly exceeding a specified LFC threshold. Here we describe the use of test inversion on TREAT to present genes ranked by a confidence bound on the LFC, while still controlling FDR.ResultsTesting the Topconfects R package with simulated gene expression data shows the method outperforming current statistical approaches across a wide range of experiment sizes in the identification of genes with largest LFCs. Applying the method to a TCGA breast cancer data-set shows the method ranks some genes with large LFC higher than would traditional ranking by p-value. Importantly these two ranking methods lead to a different biological emphasis, in terms both of specific highly ranked genes and gene-set enrichment.ConclusionsThe choice of ranking method in differential expression analysis can affect the biological interpretation. The common default of ranking by p-value is implicitly by an effect size in which each gene is standardized to its own variability, rather than comparing genes on a common scale, which may not be appropriate. The Topconfects approach of presenting genes ranked by confident LFC effect size is a variation on the TREAT method with improved usability, removing the need to fine-tune a threshold parameter and removing the temptation to abuse p-values as a de-facto effect size.

Sign in / Sign up

Export Citation Format

Share Document